Clinical trials
Completed Phase 4 trials in Egypt
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
714 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 3 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 6 |
| 2007 | 5 |
| 2008 | 4 |
| 2009 | 5 |
| 2010 | 6 |
| 2011 | 8 |
| 2012 | 7 |
| 2013 | 13 |
| 2014 | 22 |
| 2015 | 20 |
| 2016 | 28 |
| 2017 | 58 |
| 2018 | 70 |
| 2019 | 76 |
| 2020 | 64 |
| 2021 | 71 |
| 2022 | 71 |
| 2023 | 58 |
| 2024 | 62 |
| 2025 | 44 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 714 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ain Shams University | 126 |
| Cairo University | 105 |
| Assiut University | 53 |
| Alexandria University | 37 |
| Tanta University | 36 |
| Mansoura University | 28 |
| Kasr El Aini Hospital | 16 |
| Menoufia University | 16 |
| Beni-Suef University | 14 |
| Kafrelsheikh University | 13 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Postoperative Pain | 33 |
| Diabetes Mellitus, Type 2 | 21 |
| Postpartum Hemorrhage | 13 |
| Agnosia | 12 |
| Pain | 12 |
| Infertility | 11 |
| Hypertension | 10 |
| Diabetes Mellitus | 9 |
| Infertility, Female | 9 |
| Non-alcoholic Fatty Liver Disease | 9 |
Trials
Showing 1 to 25 of 714. Each trial links to its page on Pharma Observatory.
614 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.